Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Saluda Medical

Request full access

Dedicated to improving the lives of people by providing personalized, responsive, and efficient neuromodulation therapy (spinal cord stimulation )

Sydney, AustraliaFounded 2013Health Tech & Medtech

About Saluda Medical

Saluda Medical is a pioneering healthcare startup that operates in the field of neuromodulation, specifically spinal cord stimulation (SCS). The company has developed a unique technology that measures the spinal cord's physiological response to stimulation, using Evoked Compound Action Potentials (ECAPs). ECAPs are electrical signals generated by the nervous system, and Saluda's technology allows for the first time, an objective measurement of these signals in the spinal cord.

The company's primary product is the Evoke® System, which uses ECAPs to provide smart neuromodulation therapy. This system listens and responds to each patient's unique neural signature, providing a more personalized and effective treatment. The Evoke® System has shown clinical superiority in a double-blinded, randomized clinical trial, demonstrating enduring patient outcomes.

Saluda Medical's business model revolves around providing this innovative technology to clinicians and healthcare providers. By offering a more objective and accurate measure of neural activation, the company empowers clinicians to provide more consistent pain relief to their patients. This is particularly important as neural activation is the mechanism that drives pain inhibition.

In terms of future potential, Saluda's proprietary SmartLoop™ technology could have broad applications in the field of neuromodulation, including therapies such as vagal nerve, sacral nerve, and deep brain stimulation. This suggests that the company has a significant growth potential in the expanding market of neuromodulation therapies.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2025
Employees
482
Open positions
15
Dealroom signal
72.1/100
Industry
Health
Sub-industry
Medical Devices
Sector
Neurology, Neuromodulation and Neurostimulation, Chronic Disease, Spinout, Tech for Patients, Hard Tech, pain care, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
POST IPO DEBTDebt Jun 2026 $25M — Perceptive Advisors ↗
IPOOther financing Dec 2025 $65M $501M Undisclosed ↗
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Saluda Medical website traffic

Latest recorded traffic for Saluda Medical is 7.1K monthly website visits, down 12.3% over the last three months. Saluda Medical's team declined 1% over the past year.

Latest monthly visits7.1K 3-month web change-12.3% 1-year team growth-1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Saluda Medical in the Sydney ecosystem

Live from Dealroom

The Saluda Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • BioScience Managers Limited

Series B and later11 investors entered at this stage

Other known investors1 additional known investor

  • CSIRO
Team profiled 19 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Saluda Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.